IMMUNOHISTOCHEMICAL CHARACTERISTICS OF MONOCYTOID B-CELL LYMPHOMA, MANTLE ZONE LYMPHOMA, SMALL LYMPHOCYTIC LYMPHOMA (OR B-CHRONIC LYMPHOCYTIC-LEUKEMIA), AND HAIRY-CELL LEUKEMIA

被引:0
作者
OKA, K [1 ]
MORI, N [1 ]
YATABE, Y [1 ]
机构
[1] NAGOYA UNIV,SCH MED,DEPT PATHOL,NAGOYA,AICHI 466,JAPAN
关键词
CHRONIC LYMPHOCYTIC LEUKEMIA; HAIRY CELL LEUKEMIA; IMMUNOHISTOCHEMISTRY; LOW GRADE B CELL LYMPHOMAS; MANTLE ZONE LYMPHOMA; MONOCYTOID B CELL LYMPHOMA; SMALL LYMPHOCYTIC LYMPHOMA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biopsy specimens obtained from 2 patients with monocytoid B cell lymphoma, 7 with mantle zone lymphoma, 7 with small lymphocytic lymphoma or B chronic lymphocytic leukemia, and 6 with hairy cell leukemia were investigated using an immunohistochemical method to detect their immunophenotypic characteristics. Periodate-lysine-paraformaldehyde-fixed frozen biopsies from the lymph node, peripheral blood, bone marrow, spleen, tonsil, lung, and stomach were studied. Monocytoid B cell lymphoma exhibited the immunophenotype of surface(s) IgD-/DRC-1-/Leu-1(CD5)-/Leu-MS(CD11c)-,+/- on the neoplastic cells or neoplastic lesions, mantle zone lymphoma exhibited that of sIgD+/DRC-1++/Leu-1-,+/Leu-M5-, small lymphocytic lymphoma or B chronic lymphocytic leukemia that of Leu-1+/sIgD-,+/DRC-1->+/Leu-M5-, and hairy cell leukemia that of Leu-M5++/sIgD->>+/Leu-1->>+/DRC-1-. We therefore suggest that these four types of lymphomas can be differentiated by a combination of anti-sIgD, DRC-1, Leu-1, and Leu-M5 monoclonal antibodies based on their immunophenotypic characteristics.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 50 条
[41]   Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma [J].
Barrientos, Jacqueline C. .
FUTURE ONCOLOGY, 2016, 12 (18) :2077-2094
[42]   Leukemic mantle cell lymphoma and chronic lymphocytic leukemia: a rare composite lymphoma and literature review [J].
Etan Marks ;
Cynthia Liu ;
Bruce Raphael ;
Arnaldo Arbini .
Journal of Hematopathology, 2018, 11 :57-62
[43]   Leukemic mantle cell lymphoma and chronic lymphocytic leukemia: a rare composite lymphoma and literature review [J].
Marks, Etan ;
Liu, Cynthia ;
Raphael, Bruce ;
Arbini, Arnaldo .
JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (02) :57-62
[44]   CD5+B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma [J].
Jevremovic, Dragan ;
Dronca, Roxana S. ;
Morice, William G. ;
McPhail, Ellen D. ;
Kurtin, Paul J. ;
Zent, Clive S. ;
Hanson, Curtis A. .
LEUKEMIA RESEARCH, 2010, 34 (09) :1235-1238
[45]   Spotlight on Rituximab in Chronic Lymphocytic Leukemia, Low-Grade or Follicular Lymphoma, and Diffuse Large B-Cell Lymphoma [J].
Gillian M. Keating .
BioDrugs, 2011, 25 :55-61
[46]   Burkitt lymphoma in patients with chronic lymphocytic leukemia and other indolent B-cell lymphoid malignancies [J].
Robak, Tadeusz ;
Pluta, Agnieszka ;
Robak, Pawel ;
Janus, Agnieszka ;
Wawrzyniak, Ewa ;
Braun, Marcin .
LEUKEMIA & LYMPHOMA, 2025, 66 (08) :1376-1388
[47]   Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma to Histiocytic/Dendritic Cell Sarcoma [J].
Cai, Jennifer ;
Fernandez-Hazoury, David ;
Yoshikawa, Gene ;
Minja, Amani ;
Huang, Hehua ;
Hwang, Andrew ;
Qing, Xin .
JOURNAL OF HEMATOLOGY, 2024, 13 (05) :216-223
[48]   Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma to Interdigitating Dendritic Cell Sarcoma [J].
Fraser, Cory R. ;
Wang, Wei ;
Gomez, Mario ;
Zhang, Taotao ;
Mathew, Susan ;
Furman, Richard R. ;
Knowles, Daniel M. ;
Orazi, Attilio ;
Tam, Wayne .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (06) :928-939
[49]   IDENTIFICATION OF MONOCLONAL IMMUNOGLOBULINS AND QUANTITATIVE IMMUNOGLOBULIN ABNORMALITIES IN HAIRY-CELL LEUKEMIA AND CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
HANSEN, DA ;
ROBBINS, BA ;
BYLUND, DJ ;
PIRO, LD ;
SAVEN, A ;
ELLISON, DJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (05) :580-585
[50]   A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia [J].
Tucker, David L. ;
Rule, Simon A. .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 :979-990